Email
Password
Remember meForgot password?
    Log in with Twitter

Astrazeneca News

France says 'highly probable' EU won't renew AZ orders

Paris - The European Union is very unlikely to renew its Covid-19 vaccine contracts with pharmaceutical company AstraZeneca, a French minister said on Friday.

Hong Kong suspends its order of AstraZeneca jabs

Fpo - Hong Kong on Friday confirmed it has requested AstraZeneca suspend delivery of its Covid-19 vaccine amid fears of severe side effects and concerns over its efficacy against new variants of the coronavirus.

Australia halts AstraZeneca shots for under 50s over clot concerns

Sydney - Australia on Thursday joined a growing number of countries halting the use of the AstraZeneca coronavirus vaccine for younger people over fears it can cause serious blood clots.

AstraZeneca UK vaccine trial in children paused as clot link probed

London - A British trial of the AstraZeneca coronavirus vaccine on children has been paused, Oxford University said Tuesday, as global regulators rush to assess its possible link to rare blood clots in adults.

U.S. - Johnson & Johnson in charge of Baltimore vaccine facility

Baltimore - The U.S. Health and Human Services Department on Saturday stopped a Baltimore manufacturer from making AstraZeneca Plc’s Covid-19 vaccine, days after the facility ruined 15 million doses of Johnson&Jonson vaccine.

Seven deaths in UK among AstraZeneca jab recipients after blood clots: medical regulator

London - The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.

How AstraZeneca's errors eroded US confidence in its Covid shot

Washington - The United States was among the biggest backers of the AstraZeneca Covid vaccine, but a series of blunders by the company eroded American authorities' confidence and have delayed rollout in the world's hardest-hit country.

Merkel backs EU chief's AstraZeneca export ban threat

Berlin - German Chancellor Angela Merkel on Tuesday voiced support for EU chief Ursula von der Leyen's threat to block AstraZeneca vaccines produced in the bloc from being exported, ahead of a crunch EU summit on the escalating row.

EU chief threatens to ban AstraZeneca exports

Frankfurt - EU chief Ursula von der Leyen threatened Saturday to halt exports of AstraZeneca's Covid-19 vaccines if the bloc did not receive its promised deliveries first, escalating a row that has fanned international tensions.

Merkel says would take AstraZeneca vaccine

Berlin - Chancellor Angela Merkel said Friday she was ready to be vaccinated with AstraZeneca's coronavirus jab if she is offered it, in a bid to shore up confidence in the jab.

AstraZeneca's Pascal Soriot: the man behind the vaccine

London - Pascal Soriot has led the charge to make AstraZeneca one of the first pharmaceutical companies in the world to produce a vaccine against Covid-19.

Major European nations suspend use of AstraZeneca vaccine

The number of countries that have suspended the use of AstraZeneca's coronavirus vaccine continues to grow as Germany, France, and Italy on Monday became the latest additions to the list.

Irish, Dutch halt AstraZeneca jabs as Italy gets set for curbs

Dublin - Ireland and the Netherlands on Sunday became the latest countries to suspend their rollouts of AstraZeneca jabs over concerns about post-jab blood clots despite the firm insisting there was no risk, as most Italians were bracing for a new round of rest...

Australian PM plays down Italy vaccine blockade

Sydney - Australia's prime minister on Friday played down the impact of Italy's landmark decision to block the export of 250,000 Covid-19 vaccine doses due to be delivered.

Italy blocks export of AstraZeneca doses to Australia

Rome - Italy said Thursday it has blocked a shipment to Australia of AstraZeneca's Covid-19 vaccine in the first such export ban under an EU vaccine monitoring scheme.

Vaccine-poor Germans shunning AstraZeneca jab

Berlin - Doctors and public health officials pleaded with Germans Thursday to take up AstraZeneca vaccines against the coronavirus after muddled communication about the efficacy of the British-made jabs hit demand.

WHO OKs AstraZeneca jabs for Covid variants, over-65s

Geneva - The AstraZeneca-Oxford Covid-19 vaccine can be used for people aged over 65, and also where coronavirus variants of concern are circulating, WHO experts said Wednesday, soothing fears about the jab.

Macron: AstraZeneca vaccine 'quasi-ineffective' for over-65s

Paris - French President Emmanuel Macron said on Friday that AstraZeneca's coronavirus vaccine appeared not to be effective for people over 65 years of age.

Pfizer CEO — Not sure if vaccine will stop transmission of virus

Pfizer Inc’s CEO Albert Bourla has said that the company is “not certain” if its COVID-19 vaccine candidate developed in collaboration with German drugmaker BioNTech SE prevented the transmission of the novel coronavirus.

AstraZeneca says its vaccine needs 'additional study'

London - The head of British drug manufacturer AstraZeneca said on Thursday further research was needed on its Covid-19 vaccine after questions emerged over the protection it offers, but the additional testing is unlikely to affect regulatory approval in Europe...

AstraZeneca admits errors were made in vaccine study results

AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine.

AstraZeneca promises virus vaccine at cost price worldwide

Paris - Hopes of an effective vaccine against coronavirus becoming available rose again on Monday with AstraZeneca and Oxford University claiming success with their product, becoming the third team to do so.

Unexplained illness in volunteer puts vaccine trial on hold

A large, Phase 3 study testing a Covid-19 vaccine being developed by AstraZeneca and the University of Oxford at dozens of sites across the U.S. has been put on hold due to a suspected serious adverse reaction in a participant in the United Kingdom.

Op-Ed: Finally, some good news about COVID-19 vaccines

Oxford - Some good news at last on the vaccine front. Oxford University trials have shown good results in boosting immune responses. These are early stage trials, and raising a few issues with the possible need for boosters, but looking good at this point.

Big AZ takeover and other pharmaceutical news

As we do on a regular basis, Digital Journal has reviewed the latest developments within the pharmaceutical sector. Here AstraZeneca completes takeover of Takeda's respiratory business and Ferring Pharmaceuticals have a new nocturia treatment.

FDA approves AstraZeneca's Tagrisso as lung cancer treatment

On Friday, AstraZeneca's new lung cancer drug, Tagrisso, was granted accelerated approval by the U.S. Food and Drug Administration (FDA). The once-daily medication is a treatment for patients with advanced non-small cell lung cancer.

AstraZeneca’s study of new heart drug is completed

With the conclusion of their major clinical study, AstraZeneca’s new blood-thinning drug, Brilinta is effective in lowering the risk of death or heart attack in patients with a history of previous attacks.

AstraZeneca swings into loss on slumping drug sales

London - AstraZeneca fell into a loss in the last quarter of 2013 on a huge impairment charge caused by weak sales of its diabetes drug Bydureon, the Anglo-Swedish firm said Thursday.

GSK bribing medics with cash and 'sexual favors' (update)

'Big Pharma' company GSK is accused of bribing to government officials, doctors, hospitals and industry associations using travel agencies as conduits for the cash in China. China also states that sexual favors were offered as bribes.

AstraZeneca announces massive job cuts

The pharmaceutical company AstraZeneca has announced two rounds of significant job cuts in an attempt to boots its profitability.
  1 2 Next»

Set up a news alert for

Astrazeneca


Astrazeneca Image

AstraZeneca  Canadian office  Mississauga  Ontario
AstraZeneca, Canadian office, Mississauga, Ontario
AstraZeneca Canada Inc.

Latest News
Top News